-
-
[1] Johnson R, Gretch D, Ramabe H, et al. Memranoproliferative glomerulonephritis associated with hepatitis C virus infection[J].Ibid, 1993, 328∶465-470. [2] D’AmicoG , FornasieriA .Cryoglobulinemicglomerulonephritis:amem branoproliferativeglomerulonephritisinducedbyhepatitisCinfection[J].AmJKidneyDis, 1995, 25∶361-369. [3] Stehman-Breen C, Johnson R. Hepatitis C virus-associated glomerulonephritis[J]. Adv Intern Med, 1998, 43∶79-97. [4] Biesemier K, Falk J, Folds J, et al. Prevalence of antibodyies to hepatitis C in patients with glomerular disease[J]. Lab Invest, 1994, 70∶157A. [5] Koзовскаяв, мухинНА, гордовскаяНБ, идр.Факторрискаирогрессированиякриогобуинемическогогомеруонефрита, связанногосвирусомгеиатитаС[J].КинМед, 2001, 79 (4) ∶32-35. [6] GalliM. Viruses and cryoglobulinemia[J].Clin Exp Rheumatol, 1995, 13∶63-70. [7] Agnello V. Hepatitis C virus infection and type Ⅱ cryoglobulinemia:an immunological perspective[J]. Hepatology, 1997, 26∶1375-1379. [8] Верме bAE .Kриогобуиныикриогобуинемия[J].КинМед, 2000, 78 (2) ∶14-19. [9] Tarantino A, Campise M, Banfi G, et al. Longterm predictors of survival inessential mixed cryoglobulinemic glomerulonephritis[J].Kidneylnt, 1995, 47∶618-623. [10] ГордовскаяНЪ, АзароваВВ, АртемвеваВб, идр.Особенностикиническоготечениянефритауьоьныхскриогобуинемией[J].TepApx, 1997, (6) ∶30-34. [11] Cueto-Manzano A, Poo JL. Hepatitis C virus infection and membranoproliferative glomerulonephritis[J].Rev Invest Clin, 1995, 47 (3) ∶189-196. [12] RothD .HepatitisCvirus:thenephrologyist’sview[J].AmJKidneyDis, 1995, 25∶3-16. [13] МаышкоЕЮ, КонстантиноваНА, СеменоваЕН.Криогобуинемия, ассоцированнаясHCV -инфекцией[J].КинМед, 2001, 79 (1) ∶9-14. [14] Misiani R, Bellavita P. Interferon alfa-2a therapy in cryoglobulinemia associated with hepatitis C virus[J].N Engl J Med, 1994, 330∶751-756. [15] Tavoni A, Mosca M. Guidelines of the management of essential mixed cryoglobulinemia[J].Clin Exp Rheumatol, 1995, 13∶191-195.
本文二维码
计量
- 文章访问数: 3236
- HTML全文浏览量: 11
- PDF下载量: 826
- 被引次数: 0